Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Schattenberg

Showing results (111-120 of 333) with videos related to

Pageof 34
Sort By:
Hepatology (Baltimore, Md.)|April 1, 2022
An international survey on patterns of practice in NAFLD and expectations for therapies-The POP-NEXT projectVlad Ratziu, Quentin M Anstee, Vincent Wai-Sun Wong, et al.
Alimentary Pharmacology & Therapeutics|October 5, 2019
Raised serum Interleukin-6 identifies patients with liver cirrhosis at high risk for overt hepatic encephalopathyChristian Labenz, Gerrit Toenges, Yvonne Huber, et al.
Clinical and Translational Gastroenterology|June 23, 2020
Outcome Prediction of Covert Hepatic Encephalopathy in Liver Cirrhosis: Comparison of Four Testing StrategiesChristian Labenz, Gerrit Toenges, Jörn M Schattenberg, et al.
Plos One|March 19, 2016
The Impact of Liver Cell Injury on Health-Related Quality of Life in Patients with Chronic Liver DiseaseYvonne Alt, Anna Grimm, Liesa Schlegel, et al.
The American Journal of Gastroenterology|March 9, 2019
Development and Validation of a Prognostic Score to Predict Covert Hepatic Encephalopathy in Patients With CirrhosisChristian Labenz, Gerrit Toenges, Yvonne Huber, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 27, 2026
Effect of Essential Phospholipids in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Randomised Phase 4 Clinical TrialNorbert Stefan, Marek Hartleb, Jiangao Fan, et al.
Health and Quality of Life Outcomes|February 9, 2022
Continued alcohol consumption and hepatic encephalopathy determine quality of life and psychosocial burden of caregivers in patients with liver cirrhosisMichael Nagel, Vanessa Weidner, Sina Schulz, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 22, 2025
Limitations of Guideline-Recommended Risk Stratification in Identifying MASLD Patients for Novel Drug TreatmentsMartin Franck, Katharina John, Monika Rau, et al.
Digestive Diseases and Sciences|December 20, 2019
Symptom Burden and Treatment Response in Patients with Primary Biliary Cholangitis (PBC)Leonard Kaps, Annette Grambihler, Bethlehem Yemane, et al.
Journal of the International AIDS Society|March 16, 2023
Uncovering the NAFLD burden in people living with HIV from high- and middle-income nations: a meta-analysis with a data gap from Subsaharan AfricaRamiro Manzano-Nunez, Jesús Rivera-Esteban, Jordi Navarro, et al.
Pageof 34

Showing results (111-120 of 333) with videos related to

Sort By:
Pageof 34
Hepatology (Baltimore, Md.)|April 1, 2022
An international survey on patterns of practice in NAFLD and expectations for therapies-The POP-NEXT projectVlad Ratziu, Quentin M Anstee, Vincent Wai-Sun Wong, et al.
Alimentary Pharmacology & Therapeutics|October 5, 2019
Raised serum Interleukin-6 identifies patients with liver cirrhosis at high risk for overt hepatic encephalopathyChristian Labenz, Gerrit Toenges, Yvonne Huber, et al.
Clinical and Translational Gastroenterology|June 23, 2020
Outcome Prediction of Covert Hepatic Encephalopathy in Liver Cirrhosis: Comparison of Four Testing StrategiesChristian Labenz, Gerrit Toenges, Jörn M Schattenberg, et al.
Plos One|March 19, 2016
The Impact of Liver Cell Injury on Health-Related Quality of Life in Patients with Chronic Liver DiseaseYvonne Alt, Anna Grimm, Liesa Schlegel, et al.
The American Journal of Gastroenterology|March 9, 2019
Development and Validation of a Prognostic Score to Predict Covert Hepatic Encephalopathy in Patients With CirrhosisChristian Labenz, Gerrit Toenges, Yvonne Huber, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 27, 2026
Effect of Essential Phospholipids in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Randomised Phase 4 Clinical TrialNorbert Stefan, Marek Hartleb, Jiangao Fan, et al.
Health and Quality of Life Outcomes|February 9, 2022
Continued alcohol consumption and hepatic encephalopathy determine quality of life and psychosocial burden of caregivers in patients with liver cirrhosisMichael Nagel, Vanessa Weidner, Sina Schulz, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 22, 2025
Limitations of Guideline-Recommended Risk Stratification in Identifying MASLD Patients for Novel Drug TreatmentsMartin Franck, Katharina John, Monika Rau, et al.
Digestive Diseases and Sciences|December 20, 2019
Symptom Burden and Treatment Response in Patients with Primary Biliary Cholangitis (PBC)Leonard Kaps, Annette Grambihler, Bethlehem Yemane, et al.
Journal of the International AIDS Society|March 16, 2023
Uncovering the NAFLD burden in people living with HIV from high- and middle-income nations: a meta-analysis with a data gap from Subsaharan AfricaRamiro Manzano-Nunez, Jesús Rivera-Esteban, Jordi Navarro, et al.
Pageof 34